These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 17194556

  • 1. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    Kim CS, Sohn EJ, Kim YS, Jung DH, Jang DS, Lee YM, Kim DH, Kim JS.
    J Ethnopharmacol; 2007 May 04; 111(2):240-7. PubMed ID: 17194556
    [Abstract] [Full Text] [Related]

  • 2. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
    Sohn EJ, Kim CS, Kim YS, Jung DH, Jang DS, Lee YM, Kim JS.
    Life Sci; 2007 Jan 09; 80(5):468-75. PubMed ID: 17070554
    [Abstract] [Full Text] [Related]

  • 3. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM, Tzeng TF, Liou SS, Chang CJ.
    J Ethnopharmacol; 2009 Jul 15; 124(2):211-8. PubMed ID: 19397971
    [Abstract] [Full Text] [Related]

  • 4. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P, Eiam-Ong S, Suwanwalaikorn S.
    J Med Assoc Thai; 2006 Feb 15; 89(2):170-7. PubMed ID: 16579002
    [Abstract] [Full Text] [Related]

  • 5. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
    Tsuchida K, Makita Z, Yamagishi S, Atsumi T, Miyoshi H, Obara S, Ishida M, Ishikawa S, Yasumura K, Koike T.
    Diabetologia; 1999 May 15; 42(5):579-88. PubMed ID: 10333051
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.
    Nakagawa T, Yokozawa T, Yamabe N, Rhyn DY, Goto H, Shimada Y, Shibahara N.
    J Pharm Pharmacol; 2005 Sep 15; 57(9):1205-12. PubMed ID: 16105242
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
    Ueta K, Ishihara T, Matsumoto Y, Oku A, Nawano M, Fujita T, Saito A, Arakawa K.
    Life Sci; 2005 Apr 22; 76(23):2655-68. PubMed ID: 15792833
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF, De Vriese AS, Tilton RG, Van de Voorde J, Denner L, Lameire NH, Flyvbjerg A.
    Horm Metab Res; 2005 Jan 22; 37(1):21-5. PubMed ID: 15702434
    [Abstract] [Full Text] [Related]

  • 9. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 10. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ, Kang YS, Han SY, Lee MH, Song HK, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2008 Sep 28; 23(9):2750-60. PubMed ID: 18388116
    [Abstract] [Full Text] [Related]

  • 11. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats.
    Chen KH, Hung CC, Hsu HH, Jing YH, Yang CW, Chen JK.
    Chem Biol Interact; 2011 Mar 15; 190(1):45-53. PubMed ID: 21300041
    [Abstract] [Full Text] [Related]

  • 12. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
    Louro TM, Matafome PN, Nunes EC, da Cunha FX, Seiça RM.
    Eur J Pharmacol; 2011 Feb 25; 653(1-3):89-94. PubMed ID: 21167150
    [Abstract] [Full Text] [Related]

  • 13. Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-treated and Goto-Kakizaki rats.
    Fujii M, Takei I, Umezawa K.
    Biomed Pharmacother; 2009 Dec 25; 63(10):710-6. PubMed ID: 19217246
    [Abstract] [Full Text] [Related]

  • 14. KIOM-79 prevents apoptotic cell death and AGEs accumulation in retinas of diabetic db/db mice.
    Sohn EJ, Kim YS, Kim CS, Lee YM, Kim JS.
    J Ethnopharmacol; 2009 Jan 12; 121(1):171-4. PubMed ID: 19013511
    [Abstract] [Full Text] [Related]

  • 15. Antidiabetic effect of long-term supplementation with Siraitia grosvenori on the spontaneously diabetic Goto-Kakizaki rat.
    Suzuki YA, Tomoda M, Murata Y, Inui H, Sugiura M, Nakano Y.
    Br J Nutr; 2007 Apr 12; 97(4):770-5. PubMed ID: 17349091
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
    Cha DR, Kang YS, Han SY, Jee YH, Han KH, Han JY, Kim YS, Kim NH.
    J Endocrinol; 2004 Oct 12; 183(1):183-94. PubMed ID: 15525586
    [Abstract] [Full Text] [Related]

  • 17. KIOM-79 inhibits high glucose or AGEs-induced VEGF expression in human retinal pigment epithelial cells.
    Kim YS, Jung DH, Kim NH, Lee YM, Jang DS, Song GY, Kim JS.
    J Ethnopharmacol; 2007 May 30; 112(1):166-72. PubMed ID: 17383127
    [Abstract] [Full Text] [Related]

  • 18. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ, Buck D, Cox AJ, Zhang Y, Gilbert RE.
    Am J Physiol Renal Physiol; 2007 Aug 30; 293(2):F565-74. PubMed ID: 17522264
    [Abstract] [Full Text] [Related]

  • 19. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
    Liu IM, Tzeng TF, Liou SS, Chang CJ.
    J Food Sci; 2011 Sep 30; 76(7):H165-74. PubMed ID: 22417553
    [Abstract] [Full Text] [Related]

  • 20. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH.
    Diabetes Res Clin Pract; 2009 Feb 30; 83(2):176-82. PubMed ID: 19111363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.